Key terms
About LIFE
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest LIFE news
Yesterday
8:18am ET
Piper Sandler Reaffirms Their Buy Rating on aTyr Pharma (LIFE)
Yesterday
7:06am ET
RBC Capital Sticks to Their Buy Rating for aTyr Pharma (LIFE)
Yesterday
6:26am ET
Strong Buy Rating for aTyr Pharma as Efzofitimod Shows Promise and Financial Stability
Mar 18
2:05am ET
3 Best Stocks to Buy Now, 3/18/2024, According to Top Analysts
Mar 14
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 14, 2024
Mar 11
8:00am ET
Options Volatility and Implied Earnings Moves This Week, March 11 – March 15, 2024
Feb 21
8:05am ET
aTyr Pharma announces EAP for EFZO-FIT clinical trial participants
Feb 09
8:50am ET
Analysts Offer Insights on Healthcare Companies: aTyr Pharma (LIFE), CVS Health (CVS) and Science 37 (SNCE)
No recent press releases are available for LIFE
LIFE Financials
Key terms
Ad Feedback
LIFE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
LIFE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range